ICL to Acquire the Activity of Evogene’s Subsidiary, Lavie Bio
Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products REHOVOT, Israel, April 21, 2025 /PRNewswire/ —... Read more.
Aircastle to Announce Fourth Quarter and Full Year 2024 Results on April 23, 2025
STAMFORD, Conn., April 21, 2025 /PRNewswire/ — Aircastle Limited (“Aircastle”) announced today that it plans to release its fourth quarter and... Read more.
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ — Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational... Read more.
Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025
ALAMEDA, Calif. and TAIPEI, April 21, 2025 /PRNewswire/ — Acepodia (6976: TT) today announced the presentation of new preclinical data highlighting its proprietary... Read more.
Recurrent Energy Announces Successful Operation of 127 MW Solar Project in Louisiana
KITCHENER, ON, April 21, 2025 /PRNewswire/ — Recurrent Energy, a subsidiary of Canadian Solar Inc. (“Canadian Solar”) (NASDAQ: CSIQ), and a global... Read more.
SIMO Announces Partnership with MAYA TECHNOLOGIES GROUP and Launch of MAYA Inside at Japan IT Week 2025
Strategic collaboration between two leaders in the telecommunications market will be showcased April 23rd-25th in Tokyo, Japan SAN FRANCISCO, April 21, 2025 /PRNewswire/... Read more.
Rockbridge Growth Equity Sells GSTV to MidOcean Partners
GSTV, a Video Network Available at Fuel and Convenience Retailers Nationwide, Completed Several Major Strategic Initiatives Under Rockbridge’s Sponsorship... Read more.
Viatris Files Supplemental New Drug Applications to Japan’s Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder patients in Japan PITTSBURGH,... Read more.
Canaan Inc. Files 2024 Annual Report on Form 20-F
SINGAPORE, April 21, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), an innovator in crypto mining, today... Read more.
Steven McKay Joins Quandary Peak Research as Strategic Investment in Software Litigation Expertise
Industry veteran brings 25+ years of enterprise IT and cloud infrastructure leadership to strengthen Quandary Peak’s litigation consulting practice. LOS ANGELES,... Read more.